Rein Therapeutics, Inc. (RNTX) has 4 open-market insider trades by 4 insiders since 2025. Over the last six months insiders net bought $75K. The most active filer is Voss Value-Oriented Special Situations Fund, LP, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Voss Value-Oriented Special Situations Fund, LP | 10% Owner | — | 1 | $798K | 2025-10-28 |
| Voss Value Master Fund, LP | 10% Owner | — | 1 | $254K | 2025-11-14 |
| Josef H. von Rickenbach | Dir | — | 1 | $50K | 2026-05-27 |
| James Brian Windsor | — | — | 1 | $25K | 2026-04-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Josef H. von Rickenbach | Director | Buy | $50K | 2026-05-21 |
| James Brian Windsor | — | Buy | $25K | 2026-04-30 |
| Voss Value Master Fund, LP | 10% Owner | Buy | $254K | 2025-11-14 |
| Voss Value-Oriented Special Situations Fund, LP | 10% Owner | Buy | $798K | 2025-10-24 |
Companies that share insiders with RNTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.